NCT06248528View on ClinicalTrials.gov

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

NAActive, not recruitingINTERVENTIONAL

Enrollment

1,076

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

January 31, 2027

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE

Liver resection

Patients in the intervention group received liver resection and postoperative adjuvant therapy

PROCEDURE

Locoregional therapy

Patients in the control group received locoregional therapy and systemic therapy

Trial Locations (1)

430000

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, Wuhan

All Listed Sponsors

lead

Chen Xiaoping

OTHER

NCT06248528 - Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. | Biotech Hunter | Biotech Hunter